OINCX
Price
$24.72
Change
-$0.15 (-0.60%)
Updated
Sep 5 closing price
Net Assets
43.95B
RMFCX
Price
$60.45
Change
+$0.07 (+0.12%)
Updated
Sep 5 closing price
Net Assets
109.34B
Interact to see
Advertisement

OINCX vs RMFCX

Header iconOINCX vs RMFCX Comparison
Open Charts OINCX vs RMFCXBanner chart's image
JPMorgan Equity Income C
Price$24.72
Change-$0.15 (-0.60%)
VolumeN/A
Net Assets43.95B
American Funds American Mutual R3
Price$60.45
Change+$0.07 (+0.12%)
VolumeN/A
Net Assets109.34B
OINCX vs RMFCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
OINCX vs. RMFCX commentary
Sep 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OINCX is a Buy and RMFCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMFCX has more cash in the bank: 109B vs. OINCX (43.9B). RMFCX pays higher dividends than OINCX: RMFCX (1.24) vs OINCX (0.94). OINCX was incepted earlier than RMFCX: OINCX (28 years) vs RMFCX (23 years). OINCX (1.45) is less costly to investors than RMFCX (0.91). RMFCX is a more actively managed with annual turnover of: 31.00 vs. OINCX (20.00). RMFCX has a lower initial minimum investment than OINCX: RMFCX (250) vs OINCX (1000). RMFCX annual gain was more profitable for investors over the last year : 7.71 vs. OINCX (3.25). RMFCX return over 5 years is better than : 56.41 vs. OINCX (50.68).
OINCXRMFCXOINCX / RMFCX
Total Expense Ratio1.450.91159%
Annual Report Gross Expense Ratio1.450.91159%
Fund Existence28 years23 years-
Gain YTD9.07411.42179%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets43.9B109B40%
Annual Yield % from dividends0.941.2476%
Returns for 1 year3.257.7142%
Returns for 3 years21.1632.1666%
Returns for 5 years50.6856.4190%
Returns for 10 years111.1991.12122%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BTAI3.790.22
+6.16%
BioXcel Therapeutics Inc
CAN0.710.02
+3.26%
Canaan
TECH54.411.49
+2.82%
Bio-Techne Corp
KMT21.950.12
+0.55%
Kennametal
HSPOU12.21N/A
N/A
Horizon Space Acquisition I Corp